NO992957D0 - Mycobacterium Vaccae for nedregulering av TH2-aktiviteten til immunsystemet - Google Patents

Mycobacterium Vaccae for nedregulering av TH2-aktiviteten til immunsystemet

Info

Publication number
NO992957D0
NO992957D0 NO992957A NO992957A NO992957D0 NO 992957 D0 NO992957 D0 NO 992957D0 NO 992957 A NO992957 A NO 992957A NO 992957 A NO992957 A NO 992957A NO 992957 D0 NO992957 D0 NO 992957D0
Authority
NO
Norway
Prior art keywords
regulation
activity
immune system
mycobacterium vaccae
vaccae
Prior art date
Application number
NO992957A
Other languages
English (en)
Other versions
NO321202B1 (no
NO992957L (no
Inventor
Graham Arthur William Rook
John Lawson Stanford
Alimuddin Ismail Zumla
Original Assignee
Stanford Rook Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9626215.9A external-priority patent/GB9626215D0/en
Priority claimed from GBGB9626859.4A external-priority patent/GB9626859D0/en
Application filed by Stanford Rook Ltd filed Critical Stanford Rook Ltd
Publication of NO992957D0 publication Critical patent/NO992957D0/no
Publication of NO992957L publication Critical patent/NO992957L/no
Publication of NO321202B1 publication Critical patent/NO321202B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NO19992957A 1996-12-18 1999-06-17 Anvendelse av material avledet fra Mycobacterium vaccae til fremstilling av et medikament for nedregulering av Th2 aktiviteten til immunsystemet NO321202B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9626215.9A GB9626215D0 (en) 1996-12-18 1996-12-18 A therapeutic agent and its use
GBGB9626859.4A GB9626859D0 (en) 1996-12-24 1996-12-24 Medical treatment
PCT/GB1997/003460 WO1998026790A1 (en) 1996-12-18 1997-12-17 Mycobacterium vaccae for down-regulation of the th2 activity of the immune system

Publications (3)

Publication Number Publication Date
NO992957D0 true NO992957D0 (no) 1999-06-17
NO992957L NO992957L (no) 1999-08-10
NO321202B1 NO321202B1 (no) 2006-04-03

Family

ID=26310662

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19992957A NO321202B1 (no) 1996-12-18 1999-06-17 Anvendelse av material avledet fra Mycobacterium vaccae til fremstilling av et medikament for nedregulering av Th2 aktiviteten til immunsystemet

Country Status (18)

Country Link
EP (1) EP0951289B1 (no)
JP (1) JP4358306B2 (no)
KR (1) KR100533818B1 (no)
CN (1) CN1129453C (no)
AP (1) AP1044A (no)
AT (1) ATE307600T1 (no)
AU (1) AU730548B2 (no)
BR (1) BR9713959A (no)
CA (1) CA2273848C (no)
DE (1) DE69734461T2 (no)
DK (1) DK0951289T3 (no)
ES (1) ES2251744T3 (no)
FI (1) FI120136B (no)
HK (1) HK1021316A1 (no)
NO (1) NO321202B1 (no)
NZ (1) NZ336147A (no)
RU (1) RU2197989C2 (no)
WO (1) WO1998026790A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6361776B1 (en) * 1999-12-06 2002-03-26 Genesis Research & Development Corp. Ltd. Compounds isolated from M. vaccae and their use in modulation of immune responses
WO2001097821A1 (en) * 2000-06-19 2001-12-27 Mucoprotec Pty Ltd Immunotherapy or treating bacterial or viral infection at mucosal surfaces with probiotics, and compositions therefor.
AUPR101600A0 (en) * 2000-10-25 2000-11-16 Atheromastat Pty Ltd Compositions and methods for diagnosis and treatment of cardiovascular disorders
DE60235971D1 (de) 2001-02-20 2010-05-27 Maruho Kk Neue medizinische verwendung von alpha-antigen oder alpha-antigen-gen
AU2016281765B2 (en) * 2015-06-24 2022-06-16 Immodulon Therapeutics Limited A checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy
US11077179B2 (en) 2017-08-10 2021-08-03 Epicgenetics, Inc. Method for treating fibromyalgia and chronic fatigue syndrome

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL71683A0 (en) * 1984-04-27 1984-09-30 Yeda Res & Dev Pharmaceutical compositions for treating arthritis type diseases comprising fractions obtained from mycobacteria
GB9219425D0 (en) * 1992-09-14 1992-10-28 Univ London Therapeutic agent and its use
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions
ATE154759T1 (de) * 1990-11-08 1997-07-15 Univ London Mycobacterium als adjuvans für antigene
GB9203814D0 (en) * 1992-02-21 1992-04-08 Univ London Treatment of long term auto-immune conditions
GB9406301D0 (en) * 1994-03-30 1994-05-25 Univ London Immunotherapeutic agent and its use
AUPM864894A0 (en) * 1994-10-07 1994-11-03 Borody, Thomas Julius Treatment of bowel-dependent neurological disorders

Also Published As

Publication number Publication date
CA2273848C (en) 2008-02-19
DE69734461D1 (de) 2005-12-01
KR100533818B1 (ko) 2005-12-07
FI991384A (fi) 1999-06-17
AP1044A (en) 2002-02-18
CN1129453C (zh) 2003-12-03
DK0951289T3 (da) 2006-03-13
CA2273848A1 (en) 1998-06-25
WO1998026790A1 (en) 1998-06-25
AU730548B2 (en) 2001-03-08
ES2251744T3 (es) 2006-05-01
ATE307600T1 (de) 2005-11-15
CN1246056A (zh) 2000-03-01
AU7735598A (en) 1998-07-15
JP4358306B2 (ja) 2009-11-04
JP2001506256A (ja) 2001-05-15
RU2197989C2 (ru) 2003-02-10
KR20000069518A (ko) 2000-11-25
DE69734461T2 (de) 2006-07-06
EP0951289A1 (en) 1999-10-27
HK1021316A1 (en) 2000-06-09
BR9713959A (pt) 2000-04-11
EP0951289B1 (en) 2005-10-26
NO321202B1 (no) 2006-04-03
NZ336147A (en) 2001-03-30
FI120136B (fi) 2009-07-15
NO992957L (no) 1999-08-10
FI991384A0 (fi) 1999-06-17
AP9901553A0 (en) 1999-06-30

Similar Documents

Publication Publication Date Title
DE3689035D1 (de) Rauschminderungssystem.
NL194314B (nl) Foto-elektrisch omzettingssysteem.
ID19424A (id) Sistem pelepasan vitamin c
EP0902643A4 (en) ELECTROENCEPHALOGRAPHY-BASED ACTIVATION SYSTEM
AU1597795A (en) Method of enhancing the human immune system
DK150587A (da) Stoejundertrykkelsessystem til hoereapparat
ATE249629T1 (de) Antigenspezifischer igg-nachweis
NO983086D0 (no) Fjernstyringssystem
NL194019B (nl) Foto-elektrisch omzettingssysteem.
FI862627A0 (fi) System foer reglerande av en krans hastighet.
ID19426A (id) Sistem pelepasan vitamin c
FR2770383B1 (fr) Dispositif de retenue de bebe et berceau le comportant
NO975941D0 (no) Cateringvogn med bremseanordning
KR930702893A (ko) 상보시스템을 저해하거나 또는 면역활성을 억제하는 성분물
NO992957D0 (no) Mycobacterium Vaccae for nedregulering av TH2-aktiviteten til immunsystemet
FI850999L (fi) System foer distribuering av aonga pao en pappersbana.
DK0769118T3 (da) Vand-damp-adskillelsesindretning
IT8619831A0 (it) Insonorizzante ed impermeabile. rivestimento per pianali di veicoli
DE69022936D1 (de) Beschleunigungsmessaufnehmer und Beschleunigungsmesssystem.
HUP0001602A3 (en) Mycobacterium vaccae for down-regulation of the th2 activity of the immune system
DE3684701D1 (de) Ereignisverteilungs- und -kombinationssystem.
FR2723277B1 (fr) Convertisseur analogique-numerique et systeme de conversion analogique-numerique mettant en oeuvre ledit convertisseur
NL192956B (nl) Inrichting voor verhindering van kalkafzetting.
ZA9711375B (en) Treatment material and methods for down-regulation of Th2 activity of the immune system.
ES2014480B3 (es) Sub-unidad de motor de freno.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees